Back to mobile site

Baird Maintains a 'Outperform' on Celgene (CELG); Nothin' But Upside

July 12, 2012 11:23 AM EDT Send to a Friend
Baird maintains a 'Outperform' on Celgene (NASDAQ: CELG) price target of $78.00.

Analyst, Christopher Raymond, said, "Incrementally positive on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login